What's breaking now, across thousands of outlets.
The FDA’s long-awaited expedited investigational new drug pilot program began accepting applications Tuesday, with top agency officials incorporating public feedback into who should qualify. Karim Mikhail and Michael Davis, the newly named permanent directors of ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
As the European Union reconsiders pesticide safeguards, South Africa has a crucial window to reform its nearly 80-year-old regulatory framework and protect public health and children's development.
Thousands of people visit emergency departments with headaches every year, but research suggests the way these visits are recorded may be hiding important clues about patients' needs.
The French biotech Axoltis Pharma reported a Phase 2 failure in ALS on Tuesday morning, but suggested it found a small signal to move the drug forward amid a noisy dataset.
A recently-launched Medicare experiment that pays for technology to help people manage chronic conditions is expanding.
Shady surrogacy practices in the U.S. are raising concerns around mother-child safety and industry regulation, a CBS News investigation finds. Katrina Kaufman has more.
Nyaribo said the campaign was a proactive measure to prevent FMD, which poses a threat to the livestock sector and farmers' livelihoods.
